To analyze mistakes and misconduct in multidisciplinary and specialized biomedical journals.
In biomedicine, PubMed is the largest, most informative, and well-organized search platform, which retrieves sources from the MEDLINE database and PubMed Central (PMC) digital archive. It contains more than 23 million records, including 2.7 million references from PMC. All citations to MEDLINE-indexed sources are tracked by Scopus and influence the impact indicators in the SCImago Journal & Country Rank portal. Optimal searches through PubMed imply the use of the terms listed in the Medical Subject Headings (MeSH) controlled vocabulary (1) .
The MeSH vocabulary registered the following terms/publication types, which can be entered into PubMed searches for analyzing mistakes and misconduct in biomedical publications: published erratum (or errata, or corrigenda; first introduced in 1991), duplicate publication (1991), and retracted publication (1989) .
An erratum is published by an author, editor, or publisher, when a minor, correctable mistake is noticed in the author by-lines, text, or graphical material of an index publication. The validity of conclusions in the index publication is not questioned, and its content remains unchanged, with a link to the published errata in PubMed. Authors themselves are usually responsible for minor mistakes. The reviewers' oversight, "soft" attitude throughout the review process, automatic formatting, and superficial proofreading may all lead to incorrect publications. The reasons of mistakes are mentioned in the errata.
Duplicate, or multiple, or redundant publication is a form of academic misconduct, resulting from dual or multiple submissions of a nearly identical or identical work to several journals. Duplicates do not inform reviewers, editors, and publishers about previous submission or publication of the same work. Delays with processing manuscripts in some journals and lack of proper guidance in the instructions to authors may be the reasons of duplication committed by some inexperienced authors. This is why some editors formally urge their authors to submit exclusive, original material with "high scientific and ethical quality" (2). Overlapping manuscripts can be products of self-plagiarism, salami slicing, and augmentation of previous publications (2-4). Overlapping scientific materials overburden the reviewers' time and confuse processing of scientific evidence in systematic reviews and meta-analyses (5, 6) . Duplicate articles sometimes violate the publishers' copyrights and require retractions. The complexity of forms of covert duplication on the one hand, and deficient cross-indexing of duplicates in bibliographic databases on the other make it impossible to reveal the real frequency of the misconduct. Notices of duplication are often published in PubMed, but are not properly anchored by proper MeSH terms and do not always disclose the origins of the duplication. Duplicates beyond the PubMed platform, including non-English ones, are not tracked. Even simultaneous, ethical publication of practice guidelines in several journals is not always properly documented, making it difficult to distinguish unethical duplication from acceptable secondary publication.
Retracted publications are better represented in PubMed and designated as separate publication types in the MeSH hierarchy. Unless there is a copyright violation, each of the retracted items remains on the publisher's website with a clear mark of the withdrawal from press. A retraction of publication is a freely available, indexed note, which can be issued by authors, editors, or publishers of the index publication to state the reasons of retraction and to avoid further reliance on and citations of poor quality and potentially harmful for health care sources (7) . Retractions are issued because of fraud, inconsistent reporting, mistakes, plagiarism, duplication, legal (copyrights violation) and ethical concerns (absence of institutional approval), disputed authorship, and production errors (8) .
Analyzing updates on corrections, duplicate, and retracted publications in PubMed is an exercise for authors, reviewers, and editors, which may help avoid future mistakes at various stages of scientific research and publishing. We therefore aimed to analyze mistakes and misconduct in multidisciplinary and specialized biomedical journals.
MethoDs
We conducted searches through PubMed to retrieve errata, duplicate, and retracted publications (as of ] ). Correlations between country-based impact indicators and publication records showed a significant association of total number of publications with duplicate (r s = 0.86, P < 0.001) and retracted items (r s = 0.81, P < 0.001). A similar trend was found between country-based h-index, the integrative metric of productivity and citations, and duplicate (r s = 0.74, P < 0.001) and retracted publications (r s = 0.66, P < 0.001) (Figures 2 and 3). Table 3 (r s = 0.56, P < 0.001; Figure 4) . The only journal with a strikingly large number of retractions, which is not listed in Table 3 , is Anesthesia & Analgesia (63 items), with the h-index of 130 being ranked in the 329 place in the SCImago database.
Quantitative records of duplicate and retracted items of the thirty-seven rheumatology journals visible in PubMed and listed in the SCImago database are presented in Table  4 . Only six items of these journals were tagged as duplicates (10) (11) (12) (13) (14) (15) . Of these, one editorial from the USA was a simultaneous, ethically acceptable publication in Arthritis & Rheumatism (10 (14) , and commented on in an erratum in 2009. The twenty-two retracted articles were unevenly distributed across rheumatology journals .
No association between the number of retractions and the impact indicators of rheumatology journals was revealed. 
DisCussioN
A recent report on the frequency of errata claimed that "the proportion of errata has remained relatively constant since the 1970s" (38) . However, our analysis proved that the publication of these notes boosted in 2013, mostly because of self-corrections in PLOS One. This relatively new and large open-access journal appears to have adopted a "publish first, judge later" publishing model (39) . Our searches also revealed an increase of duplicate items, which mostly came to the light in the digitization and open-access era. This bit of information prompts "busy" reviewers and editors to be more vigilant and check certain types of submissions for overlaps and text recycling.
Research environment and publishing activity in different countries seem to be critical factors of erroneous, duplicate, and unethical publishing. Our analysis, based on the author information of duplicate and retracted publications in PubMed, reveals that a sizeable amount of these items come from highly productive countries. No country or journal is immune to research misconduct and publication of incorrect, falsified, and misleading information. And the initial step toward avoiding the misconduct is to widely distribute published sources and reach out to skilled readers, who can spot minor and major mistakes. Not surprisingly, widely-read top-tier journals (eg, Journal of Biological Chemistry, Science, and Nature) and periodicals employing the open-access publishing model (eg, PLOS One) often retract or publish corrections. Moreover, time from publication to retraction of sources in the highest-impact journals is shorter than in those with lower impact, presumably due to the lack of attention of readers and authors to the latter ones (40) . Shorter time-to-retraction is particularly evident from 2002 onwards (40) , the period of proactive open-access movement (41) .
The notorious serial case of plagiarism by Bernardino Saccomanni suggests that the true extent of retractions in certain areas cannot be judged by focusing on a single subject category. Erroneous rheumatological publications are found in a range of journals covering issues in general and internal medicine, immunology, pain management, rehabilitation and physical therapy, and pharmacotherapy. Employing the commonly used term -"antirheumatic agents, " we retrieved 19 additional retracted publications from various "non-rheumatology" journals, which were not listed in Table 5 .
Inconsistencies, redundancies, unintentional mistakes, errors, and apparently misleading information are deeply rooted in biomedical literature. Uncovering the complexity and true extent of the research and publishing activities damaging the science communication is still in its early stage. The global digitization, open access, and switching to English as a universal language of scientific communication help the whole system to self-clean and enhance reporting. The PubMed search platform, interconnected with MEDLINE and MeSH thesaurus, remains the only well-organized and informative tool for analyzing erroneous and unethical biomedical reports, which should be left out at the evidence processing for systematic reviews and meta-analyses (42) . Scopus and SCImago Journal & Country Rank citation-tracking and impact-calculating databases complement PubMed by quantifying citations and overall impact of errors and misconduct.
We are still unaware how many flawed items have been published in journals not covered by PubMed. The number of journals being accepted for indexing in PubMed and archiving in PubMed Central is constantly growing, which may increase the number of corrections, detected duplications, and retractions (43).
Editors and publishers should regularly analyze in-house mistakes and oversights, which lead to erroneous publications, and open access to the index sources, accompanying them with explicit and free-to-read notices of corrections, duplications, or retractions. Such notices, indexed by various bibliographic databases, can serve educational tools for future authors and become research material, which is currently robust enough for retractions research only (44, 45) .
Peer review is one of the pillars of scholarly publishing, which is meant to prevent the evidence accumulation from the influx of unreliable and poor quality research data. Peer reviewers and editors bear their share of responsibility for selecting scientifically sound research reports. Their research experience from mainstream science countries and statistical skills often make them suitable for the reviewing and editorial work (46, 47) . To date, no study examined the role of reviewers in withdrawing redundant, plagiarized, or falsified journal submissions. It is also unknown whether the reviewers ever requested corrections or retractions post-publication. Interestingly, a study of 312 retractions from 187 journals, indexed in MEDLINE from 1988 to 2008, revealed that editors themselves issued 65 (21%) retraction notices (48) . Based on our analyses, reviewers and responsible editors may play a more active role in the rejection of retractable submissions when the authors' identity is known to them (single-blind or public peer review), online links to the authors' profile in PubMed are activated, a statistical reviewer is involved in the analysis of original research, and software is employed to check for duplicate submissions and text recycling in reviews (eg, CrossCheck TM powered by iThenticate®) (49). Our analysis of multidisciplinary and rheumatology journals, coupled with the results of a few recent studies (50,51), prompts future reviewers to be more cautious when evaluating randomized control trials and reviews, particularly from certain countries (eg, USA, Japan, China) and subject areas with high impact (drug therapy).
Reviewers, editors, and other stakeholders of science communication should be aware how the system undergoes self-cleaning. The guidance from editorial associations and expert discussions at some online forums are the current tools for avoiding or retracting unwanted publications. The International Committee of Medical Journal Editors (IC-MJE) clearly distinguished ethically acceptable secondary publications from redundancies and set rules for judging competing and complementary manuscripts (52). A guidance on how to issue corrections, "expressions of concern, " and retractions is also provided by the ICMJE (53) . In case of suspected misconduct, editors are advised to follow the guidance from the Committee on Publication Ethics (COPE). COPE published flowcharts for editors on what to do when redundant, plagiarized, or fabricated publications are suspected, which are also of interest to authors and reviewers (54) (55) (56) . Additionally, COPE experts presented an action plan for editors confronted with the absence of patients' informed consent, violation of institutional ethics restrictions, nondisclosure of conflicts of interest, and disputed authorship, all of which may require appropriate corrections or retractions (7) . Member-restricted discussions of a series of fraudulent articles are discussed at COPE to uncover reasons of misconduct and provide a message for all stakeholders of science communication. Discussions are also available at the Retraction Watch blog (http://retractionwatch.com/), which was launched in 2010. Since then, blogging on retractions has been recognized as a valuable source of information by scientists worldwide. Motto of the Retraction Watch is "tracking retractions as a window into the scientific process. " Since the launch, new cases of retractions have been selectively picked and announced to the public, thus encouraging open discussion of the authors' unacceptable behavior and the publishers' actions to prevent future retractions. A large number of cases of plagiarism, fraud, and retractions, which are commented on at the blog, relate to biomedicine. Declaration of authorship AYG designed the study and wrote the first draft of the manuscript. LA suggested additional searches and substantially revised the whole manuscript. NAA revised and corrected most sections of the article. GDK revised sections related to duplicate and retracted publications in rheumatology journals, rechecked statistical analyses, and edited the whole text and tables. All authors approved final version of the article for publication and declared responsibility for all parts of the work.
